Valtech To Unveil Cardioband Mitral Reconstruction System In Germany

(RTTNews) - Valtech Cardio Ltd. said it will officially unveil the Cardioband Mitral Reconstruction System at the upcoming PCR London Valves meeting to be held September 20 to 22, 2015, in Berlin, Germany.

The company had said last week that it received Conformité Européenne or CE Marking for the Cardioband Mitral Reconstruction System, a proprietary implantable mitral reconstruction device with a transfemoral transseptal delivery system for mitral valve repair.

The designation was based on the results of a multicenter feasibility trial that demonstrated the safety and effectiveness of Cardioband in mitral valve repair and will allow Valtech to market and sell Cardioband in the European Union.

Funded in part from investments made by HeartWare International, Inc. (HTWR) and other private investors, Valtech Cardio is headquartered in Or Yehuda, Israel.